An Interdisciplinary Approach to Development of a New Combined Medicine for Musculoskeletal Disorders
Keywords:musculoskeletal system, lesion, traumatology, pharmacotherapy, pharmaceutical development, new medicine
Musculoskeletal disorders represent a significant global health concern, affecting millions and straining healthcare systems. Addressing the complex nature of musculoskeletal disorders necessitates a multifaceted approach, one that integrates various scientific disciplines. This paper delves into the collaborative efforts employed in the development of a new combined medication tailored for musculoskeletal disorders. Bringing together expertise from pharmacology, biomedicine, physiotherapy, and bioinformatics, the research has forged a holistic pathway to medication synthesis. Key focus areas include the evaluation of molecular targets, ensuring optimal drug-drug interactions, and tailoring the therapeutic approach based on the individual patient's needs and the specific disorder's pathology. Furthermore, insights from physical therapy informed the drug development process, ensuring that the new medication aligns with rehabilitative approaches and promotes functional recovery. Advanced computational methods also played a pivotal role, enabling the prediction of drug efficacy, potential side effects, and patient response variability. Preliminary results suggest that this interdisciplinary strategy not only enhances the drug's therapeutic potential but also minimizes adverse reactions, paving the way for a more comprehensive and effective approach to managing musculoskeletal disorders. This research underscores the power of interdisciplinary collaboration on the relevance, necessity, and timeliness of the pharmaceutical development of a new combined medicine for musculoskeletal disorders based on known active pharmaceutical ingredients. The characteristics of active pharmaceutical ingredients (ketamine, analgin, diazepam) were studied in order to substantiate the composition based on a combination of evidence-selected active pharmaceutical ingredients. The composition, clinical and pharmacological properties, control regime, availability, areas of medical application, quality and safety profile were substantiated.
Osyntseva A. Clinical and pharmacological, organizational and legal, forensic and pharmaceutical research of drugs of ATC-group N01AX03 for Anesthesia. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.2. P.1-10. URL: https://doi.org/10.53933/sspmpm.v3i2.90 DOI: https://doi.org/10.53933/sspmpm.v3i2.90
Shapovalova V. Forensic and pharmaceutical risks in the organization of pharmacotherapy of covid, post-covid and long-covid disorders. COVID-19 and vaccination practice standards. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. No. 4. P.1–24. URL: https://doi.org/10.53933/sspmpm.v2i4.69. DOI: https://doi.org/10.53933/sspmpm.v2i4.69
Hayduchok I., Shapovalova V., Ishcheikin K. et al. Pharmaeconomic approaches for pharmacotherapy of Rheumatoid arthritis. Likars’ka Sprava. 2021. No. 1–2. P.70-79. DOI: https://doi.org/10.31640/JVD.1-2.2021(11). DOI: https://doi.org/10.31640/JVD.1-2.2021(11)
Shapovalov V.V., Vasina J.V., Shapovalova V.A. Neuroleptic Halopril for the want of alcoholic psychosis. Abstracts of the XI World Congress of Psychiatry, August 6–11 1999. Hamburg, 1999. Vol. 2. PO-02-75. P. 101.
Shapovalov V.V., Sorokina E.V., Shapovalova V.A. Pharmacology of new psychotropic preparation. Abstracts of the 5th World Congress on “Innovations in psychiatry - 1998”, May 19–22 1998. London, 1998. B8-9. P. 38.
Shapovalova V.A., Shapovalov V.V., Mykhailov V.S. Development of a technique of definition derivatives of phorbutirophenon by a method of highly effective liquid chromatography. Abstracts of the World Congress of Pharmacy and Pharmaceutical Sciences ’99: 59 th International Congress of FIP “Facing Challenges and Achieving Success”, September 5–10 1999. Barcelona, Spain, 1999. IPS-P-334. P. 134.
Shapovalova V.A., Shapovalov V.V., Mykhailov V.S. Halopril’s application with schizophrenia. Abstracts of the 5th World Congress on “Innovations in psychiatry - 1998”, May 19–22 1998. London, 1998. B8-10. P. 38.
Shapovalova V.A. Link between Forensic Psychiatry and Forensic Pharmacy. Abstracts of the XI World Congress of Psychiatry, August 6–11 1999. Hamburg, 1999. Vol. 2. PO-14-43. P. 300.
Shapovalova V., Kutko I., Zabolotny V. Psychopharmacology aspects in pediatrics. Abstracts of the 6th World Congress of Biological Psychiatry, June 22–27 1997, Nice, France; Biological Psychiatry. 1997. Vol. 42, N. 1S. B. 39–43. P. 97.
Zabolotny V., Shapovalova V., Shapovalov V. Valcophen’s application in clinical psychiatry children. Abstracts of the 5th World Congress on “Innovations in psychiatry - 1998”, May 19–22 1998. London, 1998. B8-11. P. 38.
Shapovalova V.A., Shapovalov V.V. The clinical efficacy of the combined drug agent Valcophen in children. Likars'ka sprava. 1999. No.1. P.124–126. URL: https://pubmed.ncbi.nlm.nih.gov/10424023/.
Shapovalova V.O., Mykhailov V.S., Shapovalov V.V. The characteristics of the development of cataleptic phenomena during the action of a new Ukrainian neuroleptic--a butyrophenone derivative--in experiments on mice. Fiziolohichnyi zhurnal. 1999. Vol.45. No.3. P.114–117. URL: https://pubmed.ncbi.nlm.nih.gov/10439301/.
Matyash M.M. A multimodal approach in the treatment of long-term consequences of mine-explosive closed cranial brain injury and post-traumatic stress disorder in ATO participants. Health-ua.com. 19.01.2018. URL: https://health-ua.com/article/33766-multimodalnij-pdhd-u-lkuvann-vddalenih-nasldkv-mnnovibuhovo-zakrito-cherepn.
Shapovalov (Jr.) V., Shapovalova V., Gudzenko A. et al. Organizational and legal analysis of the pharmaceutical provision for the most common diseases of society. International Journal of Pharmaceutical Sciences Review and Research. 2018. Vol.51. No.1. P.118-124. URL: http://globalresearchonline.net/journalcontents/v51-1/18.pdf
Shapovalova V. An Innovative multidisciplinary study of the availability of coronavirus vaccines in the world. SSP Modern Pharmacy and Medicine. 2022. Vol.2. Nо.2. P.1-17 URL: https://doi.org/10.53933/sspmpm.v2i2.45. DOI: https://doi.org/10.53933/sspmpm.v2i2.45
Shapovalova V. The ICD-11 for the twenty-first century: the first view from the organizational, legal, clinical and pharmacological aspects. SSP Modern Pharmacy and Medicine. 2022. Vol.2. N.1. P.1-13. URL: https://doi.org/10.53933/sspmpm.v2i1.37. DOI: https://doi.org/10.53933/sspmpm.v2i1.37
Shapovalov V.V. (Jr.), Zbrozhek S.I., Shapovalova V.O. et al. Organizational and legal evaluation of availability of medicines’ circulation for cancer patients Pharmacia. 2018. Vol.65. Nо.2. P.17-22. URL: http://bsphs.org/?magasine=organizational-and-legal-evaluation-of-availability-of-medicines-circulation-for-cancer-patients
Shapovalova V. Extemporaneous preparations in the pharmacotherapy of nervous system disorders: pharmaceutical management, marketing, analysis, Aapplication. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.4. P.1-7. URL: https://doi.org/10.53933/sspmpm.v3i4.111 DOI: https://doi.org/10.53933/sspmpm.v3i4.111
Gryzodub O., Shapovalov V. Quality systems in Pharmacy: multidisciplinary context of the State Pharmacopoeia of Ukraine. SSP Modern Law and Practice. 2023. Vol.3. No.1. P.1-23. URL: https://doi.org/10.53933/sspmlp.v3i1.81 DOI: https://doi.org/10.53933/sspmlp.v3i1.81
Ketamine. Normative and directive documents. Ministry of Health of Ukraine. URL: https://mozdocs.kiev.ua/likiview.php?id=1967
Chuiev Y., Shapovalova V. Interdisciplinary pharmacoeconomic study of pharmacotherapy of cupping of drunk forms of alcohol dependence: clinical and pharmacological, organizational, legal and marketing experiment. SSP Modern Pharmacy and Medicine. 2021. Vol. 1. N. 2. P. 1–12. URL: https://doi.org/10.53933/sspmpm.v1i2.24 DOI: https://doi.org/10.53933/sspmpm.v1i2.24
Han Y., Chen J., Zou D. et al. Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies. Neuropsychiatric Disease and Treatment. 2016. No. 12. P. 2859-2867. URL: https://pubmed.ncbi.nlm.nih.gov/27843321/. DOI: https://doi.org/10.2147/NDT.S117146
Ng J. et al. Efficacy of Ketamine and Esketamine on Functional Outcomes in Treatment-Resistant Depression: A Systematic Review. Journal of Affective Disorders. 2021. URL: https://www.sciencedirect.com/science/article/abs/pii/S0165032721006182. DOI: https://doi.org/10.1016/j.jad.2021.06.032
ATC-classification. Compendium on-line. URL: http://compendium.com.ua/atc.
Analgin. Normative and directive documents. Ministry of Health of Ukraine. URL: https://mozdocs.kiev.ua/likiview.php?id=8938
State Register of Medicinal Products of Ukraine. State Expert Centre of Medicines. URL: http://www.drlz.com.ua
Diazepam. Normative and directive documents. Ministry of Health of Ukraine. URL: https://mozdocs.kiev.ua/likiview.php?id=6215
How to Cite
Copyright (c) 2023 Valerii Shapovalov, Valentyn Piontkovskyi, Oleksandr Huzovatyi
This work is licensed under a Creative Commons Attribution 4.0 International License.